NCT03309722 Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression Status UNKNOWN Phase N/A
NCT03304860 Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening Status COMPLETED Phase NA
NCT03298945 Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens Status COMPLETED Phase PHASE4
NCT03289988 Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression Status UNKNOWN Phase N/A
NCT03289962 A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT03287427 MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial Status COMPLETED Phase PHASE1
NCT03280407 NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer Status UNKNOWN Phase PHASE2
NCT03275987 Promoting Cancer Screening Among Medicaid Recipients in Minnesota Status COMPLETED Phase NA
NCT03273231 The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection Status UNKNOWN Phase NA
NCT03272659 The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics Status WITHDRAWN Phase PHASE2
NCT03267316 A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03265483 Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial Status COMPLETED Phase NA
NCT03264274 Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03263429 Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03261947 A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors Status COMPLETED Phase PHASE2